Cargando…
Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors
The X-ray structure of the catalytic domain of the EphA3 tyrosine kinase in complex with a previously reported type II inhibitor was used to design two novel quinoxaline derivatives, inspired by kinase inhibitors that have reached clinical development. These two new compounds were characterized by a...
Autores principales: | Unzue, Andrea, Jessen-Trefzer, Claudia, Spiliotopoulos, Dimitrios, Gaudio, Eugenio, Tarantelli, Chiara, Dong, Jing, Zhao, Hongtao, Pachmayr, Johanna, Zahler, Stefan, Bernasconi, Elena, Sartori, Giulio, Cascione, Luciano, Bertoni, Francesco, Śledź, Paweł, Caflisch, Amedeo, Nevado, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557569/ https://www.ncbi.nlm.nih.gov/pubmed/33479666 http://dx.doi.org/10.1039/d0md00049c |
Ejemplares similares
-
Chemical Space Expansion of Bromodomain Ligands Guided
by in Silico Virtual Couplings (AutoCouple)
por: Batiste, Laurent, et al.
Publicado: (2018) -
New highlights of the syntheses of pyrrolo[1,2-a]quinoxalin-4-ones
por: Georgescu, Emilian, et al.
Publicado: (2014) -
Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma
por: Gaudio, Eugenio, et al.
Publicado: (2016) -
Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma
por: Spriano, Filippo, et al.
Publicado: (2022) -
Reevaluation of bromodomain ligands targeting BAZ2A
por: Cazzanelli, Giulia, et al.
Publicado: (2023)